Human-derived recombinant fsh for controlled ovarian stimulation
AssigneeFerring B.V.
InventorJoan-Carles Arce
Life of this patent
Estimating the term…
Abstract
Preparations including FSH, for example recombinant FSH, for use in the treatment of infertility.
Claims8
A method of treating infertility, comprising administering follicle stimulating hormone (FSH) to a patient in need of such treatment, wherein the FSH is administered at a daily dose of, or a dose equivalent to a daily dose of, 11 to 13 μg recombinant FSH to the patient, wherein the patient has a serum anti-mullerian (AMH) hormone level of <15 pmol/L, and wherein the FSH is administered together with a gonadotropin releasing hormone (GnRH) antagonist.
A method of treating infertility, comprising administering a follicle stimulating hormone (FSH) to a patient in need of such treatment, wherein the FSH is administered at a daily dose of, or a daily dose equivalent to daily dose of, 0.09 to 0.19 μg recombinant FSH per kilogram body weight of the patient, wherein the has having a serum anti-mullerian hormone level of ≥15 pmol/L, and wherein the FSH is administered together with a gonadotropin releasing hormone (GnRH) antagonist.
A method of treating infertility, comprising administering follicle stimulating hormone (FSH) to a patient in need of such treatment, wherein the FSH is administered at a daily dose of, or a dose equivalent to a daily dose of, 11 to 13 μg recombinant FSH to the patient, wherein the patient has a serum anti-mullerian (AMH) hormone level of <15 pmol/L, and wherein the FSH is administered together with human chorionic gonadotropin (hCG).
A method of treating infertility, comprising administering a follicle stimulating hormone (FSH) to a patient in need of such treatment, wherein the FSH is administered at a daily dose of, or a daily dose equivalent to daily dose of, 0.09 to 0.19 μg recombinant FSH per kilogram body weight of the patient, wherein the patient has a serum anti-mullerian hormone (AMH) level of ≥15 pmol/L, and wherein the FSH is administered together with human chorionic gonadotropin (hCG).
Dependencies are inferred from the claim text.